Browsing: Health

Health authorities in Florida are investigating a foodborne illness outbreak linked to raw milk from an unnamed farm that has resulted in 21 confirmed cases of infection. According to the Florida Department of Health, patients have contracted Campylobacter and Shiga toxin-producing E. coli (STEC) infections, with seven individuals requiring hospitalization. Six of the cases involve children under the age of 10, and at least two patients have developed severe complications associated with these bacterial infections. The Florida Department of Health issued a public advisory highlighting concerns about the farm’s sanitation practices, which officials cited as a factor in the continued emergence…

Read More

A new study has identified a potential link between the artificial sweetener sucralose and reduced effectiveness of cancer immunotherapy treatments in patients with melanoma and non-small cell lung cancer. The research, conducted by the University of Pittsburgh in collaboration with the UPMC Hillman Cancer Centre, found that patients consuming higher levels of sucralose responded less effectively to immune checkpoint inhibitors and had poorer overall survival rates than those who consumed little or none. The findings, published in Cancer Discovery, a journal of the American Association for Cancer Research, highlight how dietary choices may influence the outcome of cancer treatment. The…

Read More

The U.S. Food and Drug Administration (FDA) is calling for tighter federal control over 7-hydroxymitragynine (7-OH), a potent psychoactive compound derived from the kratom plant, citing its high potential for abuse and opioid-like effects. The agency has formally recommended classifying 7-OH as a Schedule I controlled substance, aligning it with drugs such as heroin and cocaine under the Controlled Substances Act. The move follows a surge in the popularity of 7-OH products sold in vape shops, gas stations, and online retailers. While kratom in its natural form has long been used as a stimulant or pain reliever, 7-OH appears in…

Read More

The European Medicines Agency (EMA) has issued a positive recommendation for the authorization of lenacapavir, a twice-yearly injectable medication for HIV prevention. Marketed in Europe under the name Yeytuo by Gilead Sciences, the drug is now positioned for formal approval by the European Commission, which would allow its use across all 27 European Union member states, along with Iceland, Norway and Liechtenstein. Lenacapavir is a pre-exposure prophylaxis (PrEP) medication that has demonstrated near-total effectiveness in preventing HIV transmission. In two large Phase 3 clinical trials, PURPOSE 1 and PURPOSE 2, the drug was found to be 100 percent effective among women in sub-Saharan Africa and 99.9 percent…

Read More